Cargando…
PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
Biochemical recurrence is a clinical situation experienced by 20 to 40% of prostate cancer patients treated with radical prostatectomy (RP). Prostate bed (PB) radiation therapy (RT) remains the mainstay salvage treatment, although it remains non-curative for up to 30% of patients developing further...
Autores principales: | le Guevelou, Jennifer, Achard, Vérane, Mainta, Ismini, Zaidi, Habib, Garibotto, Valentina, Latorzeff, Igor, Sargos, Paul, Ménard, Cynthia, Zilli, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438304/ https://www.ncbi.nlm.nih.gov/pubmed/34532294 http://dx.doi.org/10.3389/fonc.2021.742093 |
Ejemplares similares
-
How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
por: Achard, Vérane, et al.
Publicado: (2023) -
Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging
por: Sanaat, Amirhossein, et al.
Publicado: (2021) -
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021) -
Urinary toxicity after salvage re-irradiation for prostate cancer local failure after definitive radiotherapy: a clinical and dosimetric prognostic factors analysis
por: Dipasquale, Giovanna, et al.
Publicado: (2022) -
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)